Cargando…
Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies
It has recently been suggested that mood disorders can be characterized by glial pathology as indicated by histopathological postmortem findings. Here, we review studies investigating the glial marker S100B in serum of patients with mood disorders. This protein might act as a growth and differentiat...
Autores principales: | Schroeter, Matthias L., Abdul-Khaliq, Hashim, Sacher, Julia, Steiner, Johann, Blasig, Ingolf E., Mueller, Karsten |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878670/ https://www.ncbi.nlm.nih.gov/pubmed/20585358 http://dx.doi.org/10.1155/2010/780645 |
Ejemplares similares
-
Serum S100B Represents a New Biomarker for Mood Disorders
por: Schroeter, Matthias L., et al.
Publicado: (2013) -
The effect of continuous treatment of the NO liberator sodium nitroprusside on the serum kinetics of the brain marker protein S-100 in infants and children undergoing corrective cardiac surgery with cardiopulmonary bypass
por: Abdul-Khaliq, Hashim, et al.
Publicado: (2000) -
Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment
por: Polyakova, Maryna, et al.
Publicado: (2022) - Disorders of mood
-
Folic Acid Attenuates Glial Activation in Neonatal Mice and Improves Adult Mood Disorders Through Epigenetic Regulation
por: Zhao, Tiantian, et al.
Publicado: (2022)